The largest database of trusted experimental protocols

Atb system

Manufactured by bioMérieux
Sourced in France

The ATB system is a laboratory equipment used for antimicrobial susceptibility testing. It provides automated identification and antibiotic susceptibility results for bacterial isolates.

Automatically generated - may contain errors

2 protocols using atb system

1

Identification of Co-infecting Pathogens in Immunocompromised Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood and sputum specimens were collected from 98 patients before they received the corticoid or antibiotics treatment. Informed consent was obtained from all patients.
Sputum specimens were obtained from patient by spontaneous production. In order to avoid contamination of oral microbe, patients first gargled saline three times, prior to coughing up the sputum from deep respiratory tract when collecting specimens. Sputum specimens were promptly sent to the central laboratory of the hospital for bacterial culture and quantization. Co-infecting bacteria was analyzed using the automated bacterial identification system (ATB system, BioMérieux, Marcy-l’Étoile, France) following the bacterial or fungi culture. P. jirovecii organisms were identified microscopically by a modified Giemsa staining (Diff-Quik) method and a modified Gomori’s methenamine silver nitrate staining method as previously described.13 ,14
The blood samples were used for CD4+ T-cell measurement.12 (link) Sera were analyzed on BD FACSCalibur and the test kit. The normal critical value of CD4+ T-cell in blood was set to 410 cells/mm3 according to the reference of test kit. Patients will be considered as immunocompetent when CD4 cell >410 cells/mm3, and they will be identified as immunocompromised when the CD4+ T-cell counts <410 cells/mm3.
+ Open protocol
+ Expand
2

Identification and Antibiotic Susceptibility of E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
KP and E. coli isolates were identified using mass spectrometry (MALDITOF MS, Vitek MS, BioMérieux, France) or the Vitek 2 automated System (BioMerieux®, Marcy IEtolie, France) according to the manufacturer’s instruction. Susceptibility tests were performed with the ATB System (bioMérieux, France) or Kirby-Bauer (KB) test. The minimal inhibitory concentration (MIC) was detected by the broth microdilution approach.25 (link) The combined disc technique (ceftriaxone only and ceftriaxone-clavulanic acid) was used to detect ESBL production. Carbapenemase production was tested using the modified carbapenem inactivation method (mCIM) and the EDTA-modified carbapenem inactivation method (eCIM). Clinical Laboratory Standards Institutes (CLSI) standards (CLSI, 2016–2019) were used to interpret all susceptibility data.26–29
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!